Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers
NCT07072325
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Malignant Neoplasm
Head &Amp; Neck Cancer
Head and Neck Cancer
Advanced Head and Neck Carcinoma
Interventions
DRUG:
CD-001
Sponsor
West China Hospital